Effect of Obesity on Gentamicin Pharmacokinetics

Effect of Obesity on Gentamicin Pharmacokinetics

Item
http://www.wikidata.org/entity/Q59157843
Evaluation of extended interval dosing aminoglycosides in the morbidly obese populationDosing of antibacterial agents in obese adults: does one size fit all?Creatinine-based equations for the adjustment of drug dosage in an obese population.Antimicrobial dosing considerations in obese adult patients.Once-daily gentamicin dosing in children with febrile neutropenia resulting from antineoplastic therapy.Comparative pharmacokinetics of aminoglycoside antibiotics.Impact of hospital guideline for weight-based antimicrobial dosing in morbidly obese adults and comprehensive literature review.Interaction of obesity and infections.Aminoglycoside dosing considerations in intensive care unit patients.Management of aminoglycosides in the intensive care unit.Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients.Measurement of glomerular filtration rate in obese patients: pitfalls and potential consequences on drug therapy.
P2860

Effect of Obesity on Gentamicin Pharmacokinetics

Item
http://www.wikidata.org/entity/Q59157843
description
article
@en
im Juli 1981 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 1981
@uk
name
Effect of Obesity on Gentamicin Pharmacokinetics
@en
Effect of Obesity on Gentamicin Pharmacokinetics
@nl
type
label
Effect of Obesity on Gentamicin Pharmacokinetics
@en
Effect of Obesity on Gentamicin Pharmacokinetics
@nl
prefLabel
Effect of Obesity on Gentamicin Pharmacokinetics
@en
Effect of Obesity on Gentamicin Pharmacokinetics
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Effect of obesity on gentamicin pharmacokinetics
@en
P2093
P2860
P304
P31
P356
10.1002/J.1552-4604.1981.TB01769.X
P433
P478
P50
P577
P698
P921